InspireMD director reports 45,937 warrants each way

The two series show the same exercise prices: $1.3827 on dispositions and $0.7674 on acquisitions.

Available on EDGAR 09/23/2026 - 04:06 PM EDT Accepted by SEC EDGAR 09/23/2026 - 04:05 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

InspireMD, Inc. (NSPR) director Gary S. Roubin reported four direct warrant acquisitions and dispositions on September 18, 2026. For Series J, he reported dispositions and acquisitions involving warrants covering 15,313 common shares; for Series K, each side covered 30,624 common shares. The exercise price was $1.3827 per share for the dispositions and $0.7674 per share for the acquisitions.

Insider Trade Summary

Other: 91,874 shares

Other 4 txns

Insider ROUBIN GARY S

Role Director

Type	Security	Shares	Price	Value
Other	Series J Warrant (right to buy) F1, F2	15,313	$0.00	$0.00
Other	Series J Warrant (right to buy) F1, F3	15,313	$0.00	$0.00
Other	Series K Warrant (right to buy) F4, F5	30,624	$0.00	$0.00
Other	Series K Warrant (right to buy) F4, F6	30,624	$0.00	$0.00

Holdings After Transaction: Series J Warrant (right to buy) — 30,625 warrants (Direct); Series K Warrant (right to buy) — 30,624 warrants (Direct)

Footnotes (6)

1. F1. See Exhibit 99.1; Note 1
2. F2. See Exhibit 99.1; Note 2
3. F3. See Exhibit 99.1; Note 3
4. F4. See Exhibit 99.1; Note 4
5. F5. See Exhibit 99.1; Note 5
6. F6. See Exhibit 99.1; Note 6

Key Figures

Series J warrants disposed: 15,313 warrants covering 15,313 common shares Series J warrants acquired: 15,313 warrants covering 15,313 common shares Series K warrants disposed: 30,624 warrants covering 30,624 common shares +3 more

6 metrics

Series J warrants disposed 15,313 warrants covering 15,313 common shares September 18, 2026

Series J warrants acquired 15,313 warrants covering 15,313 common shares September 18, 2026

Series K warrants disposed 30,624 warrants covering 30,624 common shares September 18, 2026

Series K warrants acquired 30,624 warrants covering 30,624 common shares September 18, 2026

Exercise price for warrant dispositions $1.3827 per share Series J and Series K warrants; September 18, 2026

Exercise price for warrant acquisitions $0.7674 per share Series J and Series K warrants; September 18, 2026

Key Terms

Warrant (right to buy), Exercise price, Series K Warrant (right to buy)

3 terms

Warrant (right to buy) financial

"Series J Warrant (right to buy)"

Exercise price financial

"exercise price of $1.3827 per share"

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

Series K Warrant (right to buy) financial

"Series K Warrant (right to buy)"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What warrant transactions did NSPR director Gary S. Roubin report?

On September 18, 2026, Gary S. Roubin reported Series J warrant dispositions and acquisitions, each covering 15,313 common shares, and Series K dispositions and acquisitions, each covering 30,624 common shares. Exercise prices were $1.3827 per share for dispositions and $0.7674 per share for acquisitions.

Were Gary S. Roubin's NSPR warrant transactions made under a Rule 10b5-1 plan?

No Rule 10b5-1 plan is reported for the transactions.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

ROUBIN GARY S

(Last) (First) (Middle)

C/O INSPIREMD, INC.

6303 WATERFORD DISTRICT DRIVE, SUITE 215

(Street)

MIAMI FLORIDA 33126

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
InspireMD, Inc. [ NSPR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/21/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Series J Warrant (right to buy)	$1.3827	09/18/2026		J(1)			15,313	05/15/2023	(2)	Common Stock	15,313	$0	15,312	D
Series J Warrant (right to buy)	$0.7674	09/18/2026		J(1)		15,313		05/15/2023	(3)	Common Stock	15,313	$0	15,313	D
Series K Warrant (right to buy)	$1.3827	09/18/2026		J(4)			30,624	05/15/2023	(5)	Common Stock	30,624	$0	0	D
Series K Warrant (right to buy)	$0.7674	09/18/2026		J(4)		30,624		05/15/2023	(6)	Common Stock	30,624	$0	30,624	D

Explanation of Responses:

1. See Exhibit 99.1; Note 1

2. See Exhibit 99.1; Note 2

3. See Exhibit 99.1; Note 3

4. See Exhibit 99.1; Note 4

5. See Exhibit 99.1; Note 5

6. See Exhibit 99.1; Note 6

	/s/ Michael Lawless, Attorney-in-Fact for Gary S. Roubin	09/23/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)